Cic edizioni internazionali
Clinical Cases in mineral and bone metabolism

Atypical femur fractures

Mini-Review, 43 - 59
doi: 10.11138/ccmbm/2018.15.1.043
Tag this article
Full text PDF
Already from the late 1970s, some fractures of the subtrochanteric and diaphyseal region of the femur were defined “atypical” and described as “fatigue” fractures. In 2005, Odvina reported an unusual type of femoral fracture after the administration of alendronate as a result of a severely repressed bone turnover and Lenart defined femoral fractures occurring on the subtrocanteric or diaphyseal region in post-menopause women after alendronate therapy as “atypical” (AFFs). Hence the hypothesis that these fractures could be associated with the use of bisphosphonates (BP). Even with a “normal” dose of BP, the risk of fracture is highest if therapy lasts more than 5 years, although cases have recently been reported with short-term therapies.
However, many of the studies on this association did not consider the radiographic patterns and the atypical or typical radiographic definition did not evaluate the BP doses used and patient compliance; they just state if there was an association or not, and this had led to an underestimation of the real incidence of these fractures. It is the latest revision of the diagnostic criteria made in 2013 by the American Society for Bone and Mineral Research (ASBMR) Task Force to determine that to be defined as AFF, a fracture localized along the femoral diaphysis just distal from the small trochanter to just proximal to the supracondylar region must have certain clinical and radiographic patterns. They also defined exclusion and minor criteria.
In general, incidence is still low. Considering the incidence of all femoral fractures of about 460/100,000 people-year, the sub-trochanteric ones represent 7 to 10% of these, and atypical ones are even rarer: 32 per million people-year and 5, 9 per 100,000 person-years in a retrospective study from 1996 to 2009. Morbidity and mortality are similar to neck or intertrochanteric femoral fractures.
However, AFF was also found in patients who had never used BP, so BP therapy could not be the only risk factor. Among them, recent attention has been given to hypoposphatasia, picnodisostosis with mutant catepsin gene, osteopetrosis, tumors, use of glucocorticoids (GC), high body mass index (BMI) and use of proton pump inhibitors (PPI).
About pathogenesis it seems that the accumulation of microlesions, the increase of mineralization with reduced heterogeneity of mineralization, accumulation of
Advanced Glycation End-products (AGEs), reduced vascularization and reduced antiangiogenic effects, alterations of normal collagen reticulation and maturation variations of crosslinks of collagen are all factors involved.
Histological studies have demonstrated how these stress fractures occur: at the fracture site there are thin cracks that even micro-movements can distort and bring to their enlargement. In presence of predisposing conditions (femoral conformation, hypophosphatasia, use of GC ...) in BP patients, these cracks are trapped in free mineral deposits at the site of the fracture, particularly at intracortical level and act longer by suppressing just in that site where the remodeling processes are essential to healing. Initial alteration occurs precisely on the lateral cortex, which is subjected to increased stress in the subtrochanteric and diaphyseal region, causing a femur bending.
This observation has led to studies that have shown how femoral conformation plays a role in determining an increased risk of AFF. With a same BP therapy duration, for conformation characteristics, more is the lateral curvature of the femur and greater the knee valgus and more frequent are the AFFs; these features are more common in some breeds (Asiatic).
Recently AFF case reports have also been published with denosumab, a monoclonal antibody that similarly to BP has an anti-resorptive effect. Some Authors and the ASBMR themselves have outlined guidelines for AFF diagnosis and management. Following
patients who are taking BP therapy with DEXA is useful: evidence of certain pre-lesions to DEXA and the presence of prodromal symptoms are strong predictors of a subsequent fracture. Also useful is the dosage and monitoring of biochemical markers of bone remodeling.
With regard to surgical strategy, the use of an intramedullary nail is the best treatment. In cases of particularly curved femur it is more appropriate to use angular stability plates because in the case of incomplete fracture the use of a nail may turn it into complete and
because even in the case of complete fractures, the risk of non-union is higher. To date, even stopping of BP alone in the AFF suspect and the use of teriparatide as supportive drug therapy are two key elements to enable proper AFF healing.

Vol. XV (No. 2) 2018 May - August

  1. From the Editor-in-Chief
    Brandi L.M.
    doi: 10.11138/ccmbm/2018.15.2.149
  2. GCMB and PIN1: regulation of parathyroid function on a transcriptional and post-transcriptional level
    Mazzotta C., Cavalli L., Carossino A.M., Brandi M.L.
    doi: 10.11138/ccmbm/2018.15.2.151
  3. Nudging healthier behavior: psychological basis and potential solutions for enhancing adherence
    Gronchi G., Cianferotti L., Parri S., Pampaloni B., Brandi M.L.
    doi: 10.11138/ccmbm/2018.15.2.158
  4. REMS technique: future perspectives in an Academic Hospital
    Caffarelli C., Tomai Pitinca M.D., Francolini V., Alessandri M., Gonnelli S.
    doi: 10.11138/ccmbm/2018.15.2.163
  5. Complex regional pain syndrome: facts on causes, diagnosis and therapy
    de Sire A., Paoletta M., Moretti A., Brandi M.L., Iolascon G.
    doi: 10.11138/ccmbm/2018.15.2.166
  6. The role of alfacalcidol
    Nuti R., Caffarelli C.
    doi: 10.11138/ccmbm/2018.15.2.173
  7. New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis
    Adami G., Viapiana O., Rossini M., Fassio A., Orsolini G., Idolazzi L., Gatti D.
    doi: 10.11138/ccmbm/2018.15.2.177
  8. Dental implants in osteoporotic patients taking oral bisphophonates: a literature review
    Nuti N., Baldini N., D'Elia C., Gabriele G., Gennaro P., Ferrari M.
    doi: 10.11138/ccmbm/2018.15.2.183
  9. Knowledge gap among general practitioners, endocrinologists and orthopedic surgeons regarding atypical lesions and fractures of the femur due to long-term use of bisphosphonates
    Keltz E., Doronov I., Segal E., Keren Y.
    doi: 10.11138/ccmbm/2018.15.2.190
  10. The effect of static compression on the progression of bone healing. An experimental study on rabbits
    Kateros K., Galanakos S.P., Sakellariou V.I., Khaldi L., Karachalios T.
    doi: 10.11138/ccmbm/2018.15.2.196
  11. Synthesis and characterization of etidronic acid (ETD) grafted nano sheets of hydroxyapatite
    Kumar L., Kaushik A.
    doi: 10.11138/ccmbm/2018.15.2.201
  12. Short focus on thyroid function in menopause: impact on bone health
    Capozzi A., Scambia G., Lello S.
    doi: 10.11138/ccmbm/2018.15.2.209
  13. Densitometric evaluation of periprosthetic bone resorption after surgical placement of Accolade I® TMZF® hip stem at 36 months
    Parchi P.D., Ciapini G., Piolanti N., Bonicoli E., Nucci A.M., Mannocci C., Marchetti S., Scaglione M., Maffei S., Lisanti M.
    doi: 10.11138/ccmbm/2018.15.2.211
  14. The use of Poller screws in intramedullary nailing is associated with decreased callus formation
    Cundall-Curry D.J., Lawrence J.E., Fountain D.M., Krkovic M.
    doi: 10.11138/ccmbm/2018.15.2.216
  15. Ilizarov technique, satisfactory outcome with limited resources
    Khan M.S., Di Giacomo L.M., Meccariello L., Bisaccia M., Azzam W., Jatoi A., Rollo G.
    doi: 10.11138/ccmbm/2018.15.2.221
  16. Atypical femoral fractures caused by glucocorticoid and bisphosphonate prolonged therapy in premenopausal women: a case report and literature review
    Franceschet G., Censi S., Cirrone S., Gomiero W., Scaroni C., Camozzi V.
    doi: 10.11138/ccmbm/2018.15.2.227
  17. Incidence of fractures in a cohort of military personnel followed for over two decades
    Kumar KVS H., Patnaik
    doi: 10.11138/ccmbm/2018.15.2.231
  18. Multiple hereditary exostoses: metabolic diagnostics and use of anti-fracture therapy
    Masi L., Brandi M.L.
    doi: 10.11138/ccmbm/2018.15.2.235
  19. Osteolysis around the Fassier-Duval nail and spontaneous femur fracture in a young semi-professional swimmer with Osteogenesis Imperfecta type I: case report and review of literature
    Persiani P., Martini L., Ranaldi F.M., Celli M., Zambrano A., D'Eufemia P., Celli L., Villani C.
    doi: 10.11138/ccmbm/2018.15.2.242
  20. A rare cause of leg pain
    Gaudio A., Rapisarda R., Xourafa A., Zanoli L., Castellino P., Erio Fiore C.
    doi: 10.11138/ccmbm/2018.15.2.246
  21. Non-traumatic myositis ossificans circumscripta in the context of vastus medialis obliquus: a case report
    Vanelli R., Rivellino M.C., Jannelli E., Cuzzocrea F., Pietrobono L., D'Ambrosio G., Mosconi M., Benazzo F.
    doi: 10.11138/ccmbm/2018.15.2.249
  22. Hypophosphatasia in adults: a new manifestation, a new mutation. A case report
    Adami G., Viapiana O., Rossini M., Risoli M., Ganini A., Bertoldo F., Fassio A., Idolazzi L., Antoniazzi F., Gatti D.
    doi: 10.11138/ccmbm/2018.15.2.255
  23. Ewing’s sarcoma of the clavicle: a case report
    Igoumenou V.G., Economopoulou P., Agrogiannis G., Dailiana Z., Mavrogenis A.F.
    doi: 10.11138/ccmbm/2018.15.2.258
  24. Severe osteoporosis with vertebral fracturative progress in liver transplant: a case report
    Bruno R., Casabella A., Palermo A., Nardi A., Molfetta L.
    doi: 10.11138/ccmbm/2018.15.2.262
  25. Monostotic Paget’s disease of the radius: a case report
    Kokkalis Z.T., Kokkineli S., Iliopoulos I.D., Megaloikonomos P.D., Mavrogenis A.F., Panagopoulos A.
    doi: 10.11138/ccmbm/2018.15.2.267
  26. Giant myxoid neurofibroma of the hip causing bone erosion: a case report
    Sacchetti F., De Gori M., D'Arienzo A., Grossi S., Cosseddu F., Capanna R.
    doi: 10.11138/ccmbm/2018.15.2.271
  27. Hypophosphatemic osteomalacia due to tenofovir-induced Fanconi syndrome in chronic hepatitis B patient
    Olmez Sarikaya N., Nas Kırdar N., Ates M.Y., Bilir I., Bayram K.B., Oruk G.
    doi: 10.11138/ccmbm/2018.15.2.276
  28. Efficacy and safety of locally injectable vitamin C on accelerating the orthodontic movement of maxillary canine impaction (oral mesotherapy technique): prospective study
    Yussif N.M., Dehis H.M., Rahman A.R.A.
    doi: 10.11138/ccmbm/2018.15.2.280
  29. Atypical lipomatous tumor: retrospective analysis, prognostic factors and MRI in differential diagnosis
    Muratori F., Roselli G., Bettini L., Frenos F., D'Arienzo A., Campanacci D.A., Mondanelli N., Matera D., Cuomo P., Scoccianti G., Beltrami G., Totti F., Capanna R.
    doi: 10.11138/ccmbm/2018.15.2.288
  30. Integral dental treatment in patient with osteoporosis secondary to hypothyroidism prior to therapy with bisphosphonate: case report and literature review
    Zuñiga Araya M.E., Herrera J.L.A., Martínez R.E.M., Delgado J.H.O., Garrigós Portales D.
    doi: 10.11138/ccmbm/2018.15.2.294
  31. A rare case of misdiagnosis: sacrococcygeal osteoid osteoma that was treated surgically as a pilonidal sinus in a pediatric patient
    Akif Çaçan M., Karaca S., Çakır A., Uçar B.Y.
    doi: 10.11138/ccmbm/2018.15.2.300
Last Viewed articles: la lista degli ultimi x visitati.
  1. Atypical femur fractures
    Cozzi Lepri A., Capone A., Del Prete A., Soderi S., Muncibì F., Civinini R.
    doi: 10.11138/ccmbm/2018.15.1.043